A predictable, gradual reduction in the circulating levels and biological effectiveness of androgens, such as testosterone and DHEA, that occurs naturally as part of the human aging process. This decline is a clinical reality observed in both men and women, leading to a cluster of symptoms often referred to as andropause or age-related hypogonadism. Recognizing this physiological shift is critical for proactive hormonal health management and quality of life maintenance.
Origin
The concept is rooted in longitudinal endocrinology studies documenting the steady decrease in gonadal and adrenal androgen production over an adult’s lifespan. It represents a functional deterioration of the hypothalamic-pituitary-gonadal (HPG) axis and adrenal glands. The term distinguishes this natural aging phenomenon from pathological causes of androgen deficiency, framing it as a standard component of human senescence.
Mechanism
The decline is multifactorial, involving primary changes in testicular or ovarian function, and secondary changes in the pulsatile release of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) from the pituitary. Additionally, there is often an age-related increase in Sex Hormone-Binding Globulin (SHBG), which reduces the biologically active free androgen fraction. This hormonal shift contributes significantly to sarcopenia, decreased bone density, and changes in mood and cognition.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.